# 802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

> **NCT03637387** · PHASE3 · WITHDRAWN · sponsor: **Biogen**

## Conditions studied

- Trigeminal Neuralgia

## Interventions

- **DRUG:** BIIB074
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03637387
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-03-01
- **Primary completion:** 2025-08-18
- **Final completion:** 2026-09-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03637387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03637387, "802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03637387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*